This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Michigan State University, The University of Texas System. Active years: 2022.
Company Filing History:
1 out of 1,438 
1 out of 5,630 
Years Active: 2022
Title: Matt Giletto: Innovator in Chemical Compounds for Cancer Treatment
Introduction
Matt Giletto is an accomplished inventor based in Lansing, MI (US). He has made significant contributions to the field of chemical compounds, particularly in the modulation of proteasome activity. His work is aimed at addressing disorders of uncontrolled cellular proliferation, such as cancer.
Latest Patents
Matt Giletto holds a patent for "Pipecolic esters for inhibition of the proteasome." This patent relates to chemical compounds that can modulate proteasome activity, along with pharmaceutical compositions containing these compounds. The use of these compounds and compositions is intended for the treatment of various disorders, including cancer. His innovative approach provides a promising avenue for therapeutic development.
Career Highlights
Throughout his career, Matt has worked with prestigious institutions, including the University of Texas System and Michigan State University. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Matt's notable coworkers include Maria Gaczynska and Pawel A Osmulski. Their collaborative efforts have further advanced the research and development of innovative solutions in the realm of cancer treatment.
Conclusion
Matt Giletto's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. His contributions through his patent and collaborations highlight the importance of research in developing effective treatments.